Cargando…

Access to subsidised medicines, cost of medicines and health outcomes: exploring general practitioners' perceptions and experiences

Detalles Bibliográficos
Autores principales:	Babar, Zaheer-Ud-Din, Ali, Abdul, Kim, Christine, Mcintosh, James, Namdas, Malaika Samuel, Rodrigues, Erica Lourdes, Vallabh, Komal, Rew, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603631/ http://dx.doi.org/10.1186/2052-3211-8-S1-O6

Ejemplares similares

A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2012)

Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies
por: Scahill, Shane, et al.
Publicado: (2012)

Using health markets to improve access to medicines: three case studies
por: Shroff, Zubin, et al.
Publicado: (2016)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
por: Mirza, Ahmer Hameed, et al.
Publicado: (2023)

Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study
por: Jamshed, Shazia Qasim, et al.
Publicado: (2012)

Human resources health supply chains and access to essential medicines
por: Brown, Andrew, et al.
Publicado: (2014)

Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)

Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia
por: Chim, Lesley, et al.
Publicado: (2017)

Identifying priority medicines policy issues for New Zealand: a general inductive study
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

Progressivity of out-of-pocket costs for Medicare-subsidised services and medicines in Australia.
por: Di Law, Hsei, et al.
Publicado: (2022)

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan
por: Vogler, Sabine, et al.
Publicado: (2019)

Medicines and universal health coverage: challenges and opportunities
por: Bigdeli, Maryam, et al.
Publicado: (2015)

A comprehensive survey of cancer medicines prices, availability and affordability in Ghana
por: Ocran Mattila, Phyllis, et al.
Publicado: (2023)

Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa
por: Mattila, Phyllis Ocran, et al.
Publicado: (2021)

Procurement of medicines to treat cancer, 2015–2020, China
por: Pan, Mengyuan, et al.
Publicado: (2022)

Understanding and perceptions of final-year Doctor of Pharmacy students about generic medicines in Karachi, Pakistan: a quantitative insight
por: Jamshed, Shazia Qasim, et al.
Publicado: (2015)

A leap towards enforcing medicines prescribing by generic names in low- and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies
por: Merchant, Hamid A., et al.
Publicado: (2022)

Publicly subsidised smoking cessation medicines in times of COVID‐19 in Australia: An interrupted time series analysis
por: Baliunas, Dolly, et al.
Publicado: (2022)

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries
por: Gammie, Todd, et al.
Publicado: (2015)

Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
por: Brhlikova, Petra, et al.
Publicado: (2023)

Identifying priority medicines policy issues for Qatar: exploring perspectives and experiences of healthcare professionals through a qualitative study
por: Zia, Nadeem, et al.
Publicado: (2021)

Community pharmacists’ perceived value on precision medicine, desired training components, and exposure during pharmacy education: Malaysia’s experience
por: Naimat, Faiza, et al.
Publicado: (2022)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

Evaluating Price and Availability of Essential Medicines in China: A Mixed Cross-Sectional and Longitudinal Study
por: Yang, Caijun, et al.
Publicado: (2020)

Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology
por: Saeed, Amna, et al.
Publicado: (2019)

Early access to medicinal products: potential and limits
por: Evers, Pauline J
Publicado: (2014)

Herbal medicines: a cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults
por: El-Dahiyat, Faris, et al.
Publicado: (2020)

Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines
por: Zarei, Leila, et al.
Publicado: (2020)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

An Evaluation of Consumers’ Perceptions Regarding “Modern Medicines” in Penang, Malaysia
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2012)

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2021)

Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology
por: Kasonde, Lombe, et al.
Publicado: (2019)

Availability of essential medicines in Pakistan—A comprehensive document analysis
por: Rafi, Sunaina, et al.
Publicado: (2021)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

What impact does medicines shortages have on patients? A qualitative study exploring patients’ experience and views of healthcare professionals
por: Atif, Muhammad, et al.
Publicado: (2021)

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e9b3f9aipb8dlkm4kapki1dsui